Neopharma is one of the largest pharmaceutical companies in MENA region with 100% subsidiaries in USA, Japan, Brazil, UK and India. A vertically integrated business, comprising of Key intermediaries, API, R&D and Formulation facilities in regulated and emerging markets. Our global presence is supported by 10 manufacturing facilities spread across 3 continents delivering a wide range of branded & generic formulations, and active pharmaceutical ingredients (APIs). The therapeutic segments covered are acute and chronic therapies and having strong foot hold in anti-infective segment. Neopharma is primarily focusing on novel therapeutics, increasing portfolio depth and debilitating diseases at affordable prices.
View Top Employees from NeopharmaWebsite | http://www.neopharma.com |
Revenue | $20 million |
Funding | $350000 |
Employees | 383 (337 on RocketReach) |
Founded | 2003 |
Phone | +971 2 550 1000 |
Fax | +971 2 550 1199 |
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
Keywords | Active Pharmaceutical Ingredients, Pharmaceutical Products, Api Manufacturer, Research And Development, Global Pharmaceuticals |
SIC | SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Neopharma employee's phone or email?
The Neopharma annual revenue was $20 million in 2024.
Suresh Pai is the COO of Neopharma.
337 people are employed at Neopharma.
Neopharma is based in Abu Dhabi, Abu Dhabi.
The NAICS codes for Neopharma are [325, 32, 32541, 3254].
The SIC codes for Neopharma are [283, 2834, 28].